Scotiabank Maintains Sage Therapeutics(SAGE.US) With Buy Rating, Maintains Target Price $19

Scotiabank analyst George Farmer maintains $Sage Therapeutics(SAGE.US)$ with a buy rating, and maintains the target price at $19.According to TipRanks data, the analyst has a success rate of 49.4% and

moomoo NewsJun 13 07:31 ET · Ratings

Oppenheimer Maintains Sage Therapeutics(SAGE.US) With Hold Rating, Maintains Target Price $17

Oppenheimer analyst Jay Olson maintains $Sage Therapeutics(SAGE.US)$ with a hold rating, and maintains the target price at $17.According to TipRanks data, the analyst has a success rate of 44.2% and a

moomoo NewsJun 13 02:32 ET · Ratings

A Quick Look at Today's Ratings for Sage Therapeutics(SAGE.US), With a Forecast Between $8 to $25

On Jun 12, major Wall Street analysts update their ratings for $Sage Therapeutics(SAGE.US)$, with price targets ranging from $8 to $25.Morgan Stanley analyst Vikram Purohit maintains with a hold ratin

moomoo NewsJun 12 09:00 ET · Ratings

Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Wednesday.Shares of Mama's Creations Inc (NASDAQ:MAMA) fell in today's pre-market trading following fi

BenzingaJun 12 08:18 ET

HC Wainwright & Co. Reiterates Neutral on Sage Therapeutics, Maintains $25 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Sage Therapeutics (NASDAQ:SAGE) with a Neutral and maintains $25 price target.

BenzingaJun 12 06:59 ET

Express News | Sage Therapeutics Shares Fall 1.6%

ReutersJun 11 09:37 ET